Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Phase 2 (2023 published in New England Journal of Medicine) A landmark 48-week randomized controlled trial enrolled 338 adults with obesity (no diabetes)
Lee GY, Lee JW, Lee E, Yeom JS, Kim KJ, Shin HI, et al
If compounding for a vaginal application, consider almond Oil as an levigating substance
Every batch is released only after independent identity and purity testing
An oral GLP1 and GIP dual receptor agonist improves metabolic disorders in high fat-fed mice
The appropriate retatrutide dose balances efficacy with tolerability across all side effect domains, not just heart rate
US$ 29.72
US$ 27.33
US$ 22.66
US$ 22.61
US$ 28.58
